Manifestations of an overdose of VARIZIG administered intramuscularly are expected to be pain and tenderness at the injection site.


  • Individuals known to have anaphylactic or severe systemic (hypersensitivity) reactions to human immune globulin preparations should not receive VARIZIG.
  • IgA-deficient patients with antibodies against IgA and a history of hypersensitivity may have an anaphylactoid reaction.
  • VARIZIG contains less than 40 micrograms per milliliter of IgA.

Last reviewed on RxList: 2/19/2013
This monograph has been modified to include the generic and brand name in many instances.


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.